The development of atherosclerosis (AS) is closely linked to changes in the plaque
microenvironment, which consists primarily of the cells that form plaque and the associated …

Atherosclerosis can be regarded as a chronic disease derived from the interaction between
disordered lipoproteins and an unsuitable immune response. The evolution of foam cells is …

Abstract Tanshinone IIA (Tan IIA) possesses potent anti-atherogenic function, however, the
underlying pharmacological mechanism remains incompletely understood. Previous studies …

Atherosclerosis is a chronic inflammatory vascular disease that is characterized by the
accumulation of lipids and immune cells in plaques built up inside artery walls …

Atherosclerosis (AS) is a chronic inflammatory disease and leading cause of cardiovascular
diseases. The progression of AS is a multi-step process leading to high morbidity and …

The oxidized low-density lipoprotein receptor 1 (LOX-1) is one of the most important
receptors for modified LDLs, such as oxidated (oxLDL) and acetylated (acLDL) low-density …

Imidacloprid (IMI) is not only a neurotoxic agricultural pesticide but also a possible food
contaminant. The aims of this study were to (1) explore the relationship between recurrent …

Oxidized low‑density lipoprotein (ox‑LDL) induces endothelial cell apoptosis and
dysfunction. Statins are drugs that are clinically used to lower serum cholesterol levels, and …

Microneedle technology can effectively suppress the formation of hypertrophic scarring in
both animals and humans. Our previous research has revealed that this is due to the …

Increasing evidences have confirmed that long non-coding RNA LOXL1-AS1 functions in
multiple human diseases. Here, we aim to explore the function and mechanism of LOXL1 …